Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 46 (KRT8P46) is characterized as a pseudogene, meaning it is a DNA sequence resembling the Keratin 8 gene (KRT8) but has lost the ability to encode a functional protein through evolutionary mutation or sequence disruption. Pseudogenes do not contribute to normal biologic processes, are not involved in cellular pathways, and cannot serve as drug targets, disease-associated genes, or biomarkers. Occasionally, KRT8P46 may be confused with the functional Keratin 8 gene (KRT8), which codes for an intermediate filament protein important for epithelial cell structure and has clinical relevance; however, KRT8P46 itself has no such role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 46 (KRT8P46).